Tirzepatide Supply Guide for Medical Practices
Tirzepatide is a dual GLP's/GIP agonist with strong clinical results. Here is what medical practices need to know about sourcing compounded tirzepatide compliantly and at scale.
Tirzepatide Supply Guide for Medical Practices
Tirzepatide has emerged as one of the most clinically significant weight management compounds in recent years. As a dual GLP-1/GIP agonist, it works through two complementary mechanisms — and the clinical data on weight loss outcomes has been compelling enough to drive significant demand across medical spas, weight loss clinics, and prescribing physicians.
For practices that want to offer tirzepatide to their patients, understanding the supply landscape is essential.
What Makes Tirzepatide Different
Unlike semaglutide, which is a GLP-1 receptor agonist, tirzepatide acts on both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously.
This dual mechanism produces several clinically relevant effects:
- Enhanced insulin secretion in a glucose-dependent manner
- Reduced glucagon secretion which helps control blood sugar
- Slowed gastric emptying which reduces appetite and caloric intake
- Direct effects on fat metabolism through GIP receptor activity
Clinical trials have shown tirzepatide producing average weight loss of 15–22% of body weight in some patient populations — outcomes that have made it one of the most requested compounds in weight management medicine.
The Supply Landscape for Compounded Tirzepatide
Branded tirzepatide (Mounjaro, Zepbound) has faced the same access and affordability barriers as branded semaglutide. Compounded tirzepatide from licensed 503A and 503B facilities has provided an important access pathway for patients who cannot obtain or afford the branded product.
503A Supply
Patient-specific compounded tirzepatide is available through 503A-licensed compounding pharmacies. Each order requires a valid prescription for a named patient with an established patient-prescriber relationship.
503B Supply
503B outsourcing facilities can supply tirzepatide for office use to licensed healthcare facilities without patient-specific prescriptions, subject to FDA registration and CGMP compliance.
Available Strengths
Compounded tirzepatide is available across the full clinical dose range:
| Strength | Typical Use |
|---|---|
| 2.5 mg/mL | Starting dose, titration |
| 5 mg/mL | Maintenance, mid-range |
| 7.5 mg/mL | Maintenance |
| 10 mg/mL | Higher maintenance |
| 12.5 mg/mL | Higher maintenance |
| 15 mg/mL | Maximum dose range |
Custom strengths are available on request for practices with specific patient population needs.
Compliance Considerations for Tirzepatide
The regulatory environment around compounded tirzepatide has been dynamic. Here is what practices need to stay current on:
FDA Shortage Status
The FDA's shortage designation for tirzepatide has been subject to updates. The permissibility of compounding is directly tied to shortage status. Work with a supply partner that actively monitors these designations and advises you proactively.
State-Specific Rules
Some states have additional requirements for prescribing or dispensing compounded GLP-1 compounds. California, for example, has specific rules that affect how practices can operate. Know your state's current requirements.
Documentation Requirements
For 503A orders, maintain documentation of the patient-prescriber relationship, the prescription, and the clinical rationale. This documentation is your first line of defense in any regulatory inquiry.
Operational Considerations for High-Volume Practices
If tirzepatide is a significant part of your practice's revenue, supply chain reliability is not optional — it is existential.
BUD Dates Matter Short beyond-use dates create inventory management problems. With up to 12-month BUD dates available from quality suppliers, you can order in volume without waste risk.
Overnight Fulfillment Patient adherence depends on consistent access to medication. A supply partner with overnight shipping capability keeps your patients on protocol.
Custom Orders Some patients require non-standard formulations. A supply partner with custom order capability means you are not turning patients away because their needs do not fit a standard catalog.
Orders Over $10K For high-volume practices, large orders are the norm. At MedClinic Partners, orders over $10,000 are typically fulfilled within approximately two weeks.
Why MedClinic Partners for Tirzepatide Supply
We supply compounded tirzepatide through both 503A and 503B channels, across the full strength range from 2.5 mg/mL through 15 mg/mL.
Our founding team includes mass-tort attorneys who have litigated against pharmaceutical companies for 15+ years and medical operators who have run the practices you operate. We understand the compliance landscape from both sides — and we built this supply infrastructure because we could not find a partner that combined legal-grade compliance with operational reliability.
For licensed medical providers only. This content is for informational purposes and does not constitute legal or medical advice.
Explore Topics
Written by
MedClinic Partners Editorial Team
B2B Medical Supply & Compounding Experts
The MedClinic Partners editorial team is composed of licensed medical operators, compounding compliance specialists, and mass-tort attorneys with direct experience running GLP-1 and peptide programs across all 50 states. Every article is reviewed for clinical accuracy, regulatory compliance, and practical applicability before publication.
Editorial standards: All content on medclinicpartners.com is reviewed by licensed medical operators and compounding compliance specialists before publication. Articles are updated when regulatory guidance changes. This content is for licensed healthcare providers only and does not constitute medical advice.
